EFFECT OF MYOFASCIAL RELEASE WITH OR WITHOUT TAPING IN THE PATIENTS WITH HEEL SPUR; A RANDOMISED CONTROLLED TRIAL
Insights – Journal of Health and Rehabilitation · 12.06.2026 · 4 (5) · 1-12
DOI: 10.71000/4e23tn37 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Insights – Journal of Health and Rehabilitation, online erschienen am 12.06.2026. Verfasst von Dr. Sehrish Shahzad und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Plantar heel pain associated with heel spur is a common musculoskeletal problem that often limits walking, standing tolerance, and daily activity. Myofascial release is used to reduce fascial restriction and improve tissue mobility, while kinesiology taping is applied to support foot mechanics and unload the plantar fascia. Although both approaches are used in conservative rehabilitation, their combined clinical value in heel spur-related pain remains insufficiently established, particularly for function and ankle mobility.
Objective
To compare the effects of myofascial release with and without kinesiology taping on pain, foot function, and active ankle range of motion in patients with heel spur.
Methods
A randomized controlled trial was conducted on 38 participants with heel spur-related plantar heel pain. Participants were randomly allocated into Group A and Group B, with 19 participants in each group. Group A received myofascial release with standardized physiotherapy, while Group B received myofascial release with kinesiology taping along with the same baseline physiotherapy protocol. The intervention was delivered twice weekly for six weeks, comprising 12 sessions. Pain was assessed using the Visual Analog Scale, foot function through the Foot Function Index, and active dorsiflexion and plantar flexion range of motion using a universal goniometer. Data were recorded at baseline and after intervention.
Results
Final analysis included 18 participants in Group A and 17 participants in Group B. Median VAS reduced from 7.00 to 4.00 in Group A and from 7.00 to 3.00 in Group B. Pain improved significantly within both groups, but post-treatment between-group difference was not significant. FFI improved from 70.61 ± 9.27 to 40.72 ± 11.51 in Group A and from 71.41 ± 11.97 to 29.06 ± 12.95 in Group B. Dorsiflexion increased from 9.73° ± 1.69° to 14.51° ± 2.03° in Group A and from 9.64° ± 2.16° to 17.51° ± 2.19° in Group B. Plantar flexion increased from 36.13° ± 1.57° to 43.77° ± 1.97° in Group A and from 35.42° ± 2.21° to 47.22° ± 2.66° in Group B.
Conclusion
Myofascial release was effective for improving heel spur-related symptoms, while the addition of kinesiology taping produced greater improvement in foot function and ankle mobility. A combined rehabilitation approach may therefore offer better functional recovery in patients with heel spur. Keywords: Athletic Tape; Fasciitis, Plantar; Heel Spur; Musculoskeletal Manipulations; Pain Measurement; Range of Motion, Articular; Treatment Outcome.
Zitieren
APA
Shahzad, D. S., Zerish, D. Z., Tanveer, P. D. F., Zia, D. M. B., Ahmed, M., & Saleem, D. B. (2026). EFFECT OF MYOFASCIAL RELEASE WITH OR WITHOUT TAPING IN THE PATIENTS WITH HEEL SPUR; A RANDOMISED CONTROLLED TRIAL. Insights – Journal of Health and Rehabilitation, 4(5), 1-12. https://doi.org/10.71000/4e23tn37
Vancouver
Shahzad DS, Zerish DZ, Tanveer PDF, Zia DMB, Ahmed M, Saleem DB. EFFECT OF MYOFASCIAL RELEASE WITH OR WITHOUT TAPING IN THE PATIENTS WITH HEEL SPUR; A RANDOMISED CONTROLLED TRIAL. Insights – Journal of Health and Rehabilitation. 2026;4(5):1-12. doi:10.71000/4e23tn37
BibTeX
@article{Shahzad2026,
author = {Shahzad, Dr. Sehrish and Zerish, Dr. Zermeen and Tanveer, Prof Dr Fahad and Zia, Dr Muhammad Bin and Ahmed, Mohtishim and Saleem, Dr. Bisma},
title = {EFFECT OF MYOFASCIAL RELEASE WITH OR WITHOUT TAPING IN THE PATIENTS WITH HEEL SPUR; A RANDOMISED CONTROLLED TRIAL},
journal = {Insights – Journal of Health and Rehabilitation},
year = {2026},
volume = {4},
number = {5},
pages = {1--12},
doi = {10.71000/4e23tn37}
}
EUVIMED